Vorinostat in Combination With Radiation Therapy and Infusional Fluorouracil (5-FU) in Patients With Locally Advanced Adenocarcinoma of the Pancreas
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Cancer, Pancreatic Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2009 |
| End Date: | July 2011 |
Phase 1/2 Study of Vorinostat in Combination With Radiation Therapy and Infusional 5-FU in Patients With Locally Advanced Adenocarcinoma of the Pancreas
The durg vorinostat (Zolinza) is a type of drug called an histone deacetylase (HDAC)
inhibitor. It inhibits a group of enzymes called histone deacetylases. These enzymes help
cancer cells survive. By inhibiting these enzymes, vorinostat helps kill cancer cells. In
this research study vorinostat will be given along with radiation therapy and the drug 5-FU.
This is the first research study in which vorinostat will be given along with radiation
therapy and 5-FU. The purpose of this research study is to find the highest dose of
vorinostat that can be given safely along with radiation therapy and 5-FU. The
investigators will also begin to get information about whether vorinostat combined with
radiation and 5-FU may help to treat pancreatic cancer.
- Since we are looking for the highest dose of vorinostat that can be administered safely
without severe or unmanageable side effects, not everyone who participates will receive
the same dose. The dose will depend upon the number of participants enrolled on the
study and how well they have tolerated their doses.
- 5-FU will be given intravenously over 24 hours 7 days per week during each week of
radiation therapy. In order for participants to be able to receive the 5-FU as an
outpatient, they will need to have central line catheter placed.
- Radiation therapy will be given once per day, 5 days per week, for 6 weeks.
- Vorinostat is taken orally.
- Participants will be seen once per week during the 6 weeks that they are receiving
5-FU, radiation therapy and vorinostat.
We found this trial at
2
sites
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
Click here to add this to my saved trials
Click here to add this to my saved trials